Nasal Lacrimal Stent Market Size, Share, Outlook, and Opportunity Analysis, 2022-2028

 

Nasal Lacrimal Stent Market
Nasal Lacrimal Stent Market

A nasolacrimal stent is a tiny tube that is used to treat disorders like epiphora as well as congenital nasolacrimal blockage and dacryocystorhinostomy (DCR). Nasal lacrimal stent market expansion is anticipated to be fueled by the rising prevalence of nasolacrimal duct obstruction (NLDO), a frequent condition of the lacrimal system. For instance, the prevalence of nasolacrimal duct obstruction has been shown to range from 6% to 20% in neonates worldwide in 2019, according to statistics released by the NCBI (National Center for Biotechnology Information).

The nasal lacrimal stents market is anticipated to grow over the course of the forecast period as a result of continuous research on treatments for the disorders of epiphora and dacryocystorhinostomy illness. For instance, Alon Kahana from the University of Michigan funded a study in October 2019 to assess the effectiveness and safety of the slit stent II lacrimal stent for the treatment of nasolacrimal duct obstruction.

Additionally, the availability of cutting-edge products is anticipated to fuel market expansion. Products like Nunchaku and BIKA intubation system, a bicanalicular stent used to drain tears by capillary, are available from the FCI Ophthalmics Company.

Comments

Popular posts from this blog

Market Share and Revenue Analysis of the Microdermabrasion Devices Market

The Role of the Foodservice Industry in Driving the French Fries Market

The Growing Demand for Healthcare Staffing Market: Trends and Opportunities